Ads by Google
Headache & Migraine
Researchers report success for migraine prevention using an entirely new medication that targets genes linked to migraine headaches. Monoclonal antibody injection successfully reduced number of migraines per month in two phase II studies of the drugs.
The FDA has approved the first drug-free nerve stimulator for migraine headache prevention. The manufacturer, CEFALY Technology, made the announcement today in a press release. Migraine sufferers studied were able to reduce their medication use and had less frequent bouts of migraines.
Research shows that vitamin D deficiency is common in patients with headaches and chronic migraine. Since headaches are among the most common complaints encountered in neurology practice, it is wise to investigate the cause and possible treatments.
Experts have released new guidelines for treating migraine headache. What should you do and what shouldn't you do if you suffer from migraines?
Thanks to research we now understand more about migraine headaches. Experts have released new guidelines that they say are important for patients and clinicians when it comes to treating migraines.